COCRYSTAL PHARMA, INC. (COCP) Return on equity 2020–2021
COCRYSTAL PHARMA, INC. (COCP) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-27.0%FY2021 · since FY2020: -37.5% → -27.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2021 | -27.0% | +10.5 pp |
| FY2020 | -37.5% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More COCP financial trends
COCP RevenueCOCP Net incomeCOCP Net marginCOCP Gross profitCOCP Gross marginCOCP Operating incomeCOCP Operating marginCOCP Operating cash flowCOCP Free cash flowCOCP Capital expendituresCOCP Stock buybacksCOCP Dividends paidCOCP Total assetsCOCP Total liabilitiesCOCP Shareholders’ equityCOCP overview →